158 related articles for article (PubMed ID: 22706419)
1. The effects of short-term nicotine administration on behavioral and oxidative stress deficiencies induced in a rat model of Parkinson's disease.
Ciobica A; Padurariu M; Hritcu L
Psychiatr Danub; 2012 Jun; 24(2):194-205. PubMed ID: 22706419
[TBL] [Abstract][Full Text] [Related]
2. Intranigral lipopolysaccharide administration induced behavioral deficits and oxidative stress damage in laboratory rats: relevance for Parkinson's disease.
Hritcu L; Ciobica A
Behav Brain Res; 2013 Sep; 253():25-31. PubMed ID: 23850357
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus.
Bild W; Hritcu L; Stefanescu C; Ciobica A
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():79-88. PubMed ID: 23266710
[TBL] [Abstract][Full Text] [Related]
4. The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.
Ciobica A; Olteanu Z; Padurariu M; Hritcu L
J Physiol Biochem; 2012 Mar; 68(1):59-69. PubMed ID: 22006204
[TBL] [Abstract][Full Text] [Related]
5. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
Kopalli SR; Noh SJ; Koppula S; Suh YH
Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
7. Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease.
Hritcu L; Ciobica A; Stefan M; Mihasan M; Palamiuc L; Nabeshima T
Neurosci Res; 2011 Sep; 71(1):35-43. PubMed ID: 21663772
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Hritcu L; Foyet HS; Stefan M; Mihasan M; Asongalem AE; Kamtchouing P
J Ethnopharmacol; 2011 Sep; 137(1):585-91. PubMed ID: 21704692
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats.
Kumar A; Seghal N; Padi SV; Naidu PS
Eur J Pharmacol; 2006 Dec; 551(1-3):58-66. PubMed ID: 17027965
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations.
Ferro MM; Bellissimo MI; Anselmo-Franci JA; Angellucci ME; Canteras NS; Da Cunha C
J Neurosci Methods; 2005 Oct; 148(1):78-87. PubMed ID: 15939479
[TBL] [Abstract][Full Text] [Related]
12. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I
J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease.
Kumar P; Kaundal RK; More S; Sharma SS
Behav Brain Res; 2009 Feb; 197(2):398-403. PubMed ID: 18983875
[TBL] [Abstract][Full Text] [Related]
14. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
15. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model.
Baluchnejadmojarad T; Roghani M; Nadoushan MR; Bagheri M
Phytother Res; 2009 Jan; 23(1):132-5. PubMed ID: 18693302
[TBL] [Abstract][Full Text] [Related]
17. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat.
Yu YP; Ju WP; Li ZG; Wang DZ; Wang YC; Xie AM
Brain Res; 2010 Jun; 1336():58-65. PubMed ID: 20399757
[TBL] [Abstract][Full Text] [Related]
18. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
[TBL] [Abstract][Full Text] [Related]
19. Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.
Soto-Otero R; Méndez-Alvarez E; Hermida-Ameijeiras A; López-Real AM; Labandeira-García JL
Biochem Pharmacol; 2002 Jul; 64(1):125-35. PubMed ID: 12106613
[TBL] [Abstract][Full Text] [Related]
20. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
